Stock Price
12.56
Daily Change
-0.02 -0.16%
Monthly
-12.72%
Yearly
-70.38%
Q3 Forecast
12.48

Tandem Diabetes Care reported $4.19M in Interest Income for its fiscal quarter ending in March of 2025.



Financials
Assets USD 875.74M
Cost of Sales USD 114.82M
Current Assets USD 614.82M
Debt USD 449.01M
EBIT USD -31.86M
EBITDA USD -1.85M
Employees 2.65K
Interest Income USD 4.19M
Loan Capital USD 309.15M
Net Income USD -52.4M
Operating Expenses USD 272.54M
Operating Profit USD -31.86M
Pre-Tax Profit USD -57.72M
Sales Revenues USD 240.68M
Stock USD 142.57M
Trade Creditors USD 55.84M
Trade Debtors USD 128.44M

Interest Income Change Date
Abbott USD 71M 11M Jun/2025
Align Technology USD 5.32M 3.21M Mar/2025
AtriCure USD 941K 101K Jun/2025
Baxter International USD 17M 7M Mar/2025
Becton, Dickinson and Co. USD 5M 0 Jun/2025
Boston Scientific USD 4M 3M Dec/2022
Dexcom USD 28M 500K Jun/2025
Edwards Lifesciences USD 64M 64M Dec/2024
Eli Lilly USD 40M 8.3M Jun/2025
Globus Medical USD 815K 3.08M Dec/2024
ICU Medical USD 2.52M 716K Jun/2025
Insulet USD 10.1M 200K Jun/2025
Integra LifeSciences USD 4.71M 290K Jun/2025
Intuitive Surgical USD 88.7M 1.7M Jun/2025
J&J USD 332M 51M Mar/2025
Masimo USD 600K 800K Jun/2025
Medtronic USD 114M 23M Jan/2025
Merit Medical Systems USD 3.76M 29K Jun/2025
Roche Holding CHF 2M 12M Dec/2020
Stryker USD 38M 9M Mar/2025
Tandem Diabetes Care USD 4.19M 318K Mar/2025
Teleflex USD 1.64M 274K Jun/2025